Left Atrial Appendage Closure Devices Market - By Product, By Procedure, By End Use – Global Forecast, 2024 – 2032

Key players in the market include Abbott Laboratories, AtriCure, Boston Scientific Corporation, Lepu Medical Technology, LifeTech Scientific, MicroPort Scientific Corporation, Nanjing YDB Technology, and Shanghai Push Medical Device Technology.

The North America market recorded USD 1.3 billion in 2023 and is projected to grow at a 17.6% CAGR from 2024 to 2032, driven by the presence of major industry players and increasing product demand.

The endocardial LAA devices segment generated USD 1.6 billion in revenue in 2023, owing to the rising demand and awareness of their benefits in minimizing the risk of LAA blood clots.

The global left atrial appendage closure devices industry was valued at USD 1.8 billion in 2023 and is expected to grow at a 19.2% CAGR from 2024 to 2032, driven by the increasing prevalence of atrial fibrillation and technological advancements.